Thank you to all who joined us live for PrimaryCareNOW on Friday–Saturday, July 15–16. If you were not able to join us, some sessions have been recorded and are available below.
CME/CE Accredited Session
Sponsored by Industry
Click For Session Details
Session Times Listed in ET
Paul E. Sax, MD
This case-based, interactive lecture will cover the current epidemiology of HIV in the United States, and then focus on issues critical for the primary care provider – HIV testing, identification of acute infection, initiating a baseline work-up, and understanding the basics of antiretroviral therapy. HIV prevention will be covered citing both the pre- and post-exposure prophylaxis strategies.
Clinical Director, Division of Infectious Diseases, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA
Jennifer Haley, MD
One in five Americans will develop skin cancer by the age of 70. This session will provide an overview of the major types of skin cancers and precancers, as well as provide guidance in distinguishing these from common benign tumors. This session will also equip the primary care provider with information regarding treatment and prevention of both benign and malignant skin tumors.
Associate Clinical Professor of Medicine/Dermatology, David Geffen School of Medicine at UCLA, Los Angeles, CA
Beyond Excision – A Biological Approach to Treat Uncontrolled Gout with Tophi
Jeff R. Peterson, MD
Dr. Jeff Peterson will review how gout is so much more than the symptomatic pain associated with episodic flares. Tophi can cause bone erosions, but urate deposits may be found in other areas of the body outside of the metatarsophalangeal joint of the big toe. Learn about the common myths and misperceptions along with how to recognize uncontrolled gout. You will also learn about a pharmacologic option to treat these patients.
Western Washington Medical Group, Fellow, American College of Rheumatology, President, Washington Rheumatology Alliance, Director, Northwest Rheumatism Society, Bothell, WA
Sponsored by Horizon Therapeutics
COPD: Simplifying a Complex Paradigm for Busy Clinicians
Pamela Kushner, MD, FAAFP
This session will provide clinically relevant information regarding the management of patients with COPD and focuses on establishing a valid diagnosis, avoiding common pitfalls in assessment, reducing symptoms and preventing exacerbations.
Clinical Professor, University of California Irvine Medical Center, Director, Kushner Wellness Center, Los Alamitos, CA
Sponsored by GlaxoSmithKline
Nicholas Pennings, DO, FOMA | Angela Fitch, MD, FACP, FOMA
Obesity is a serious chronic illness that requires long-term management; however, it is also drastically underdiagnosed and undertreated. Arm yourself with a concrete understanding of the physiologic factors that contribute to obesity so that you can effectively manage this disease and prevent comorbid conditions. Hear strategies for developing personalized treatment plans based on current and emerging pharmacotherapies. Most importantly, identify biases that may be hindering your care of patients with obesity.
Chair of Family Medicine, Associate Professor of Family Medicine, Director, Campbell University Health Center, Campbell University School of Osteopathic Medicine
Associate Director Weight Center, Massachusetts General Hospital, Boston, MA
Supported by Novo Nordisk Inc.
Daniel Press, MD, MMSc | Shirah Vollmer, MD
What do primary care providers need to know about depression and ADHD? Join expert faculty as they review important questions they get asked about these topics!
Associate Professor of Neurology, Harvard Medical School, Chief, Cognitive Neurology Unit, Beth Israel Deaconess Medical Center, Boston, MA
Clinical Professor of Psychiatry, David Geffen School of Medicine at UCLA, Los Angeles, CA
A Clinician’s Perspective on Managing Patients with Asthma
Russell A. Settipane, MD
Asthma is a significant public health concern in the US, making its diagnosis and management in clinical practice critically important, especially with recent increasing trends in prevalence and morbidity. With the help of engaging case-studies, this session will include discussions on the identification, diagnostic workup, and effective management of asthma. It will also review the assessment of symptom control and severity in patients with asthma.
Clinical Professor of Medicine, The Warren Alpert Medical School of Brown University
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.
An Evolving Treatment Paradigm for Chronic Heart Failure in Primary Care
John E. Anderson, MD
This program will review recent developments in the treatment of patients with chronic heart failure and discuss the important role of the primary care physician.
The Frist Clinic, Nashville, Tennessee
Sponsored by Novartis Pharmaceuticals Corporation
Charles Vega, MD, FAAFP
Stay up to date with the latest USPSTF recommendations for screening and preventive interventions in primary care. Hear about important changes regarding which patients should be screened for colorectal cancer, lung cancer, and hepatitis C virus infection. Walk away from this session with a firm grasp of the evidence of benefits vs harms for each of these recommendations so that you and your patients are positioned to make the best decisions for their care.
Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine, Irvine, CA
Neil Skolnik, MD
This lecture will discuss the underappreciated health benefits of exercise on a range of medical problems. It provides clinicians with the information they need to make the decision to emphasize exercise as an important part of preventive health in the office and a practical, effective approach to advising patients in the office.
Professor, Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, Associate Director, Family Medicine Residency Program, Abington Memorial Hospital, Abington, PA
Path To Diagnosis, Mapping Symptoms of Inflammatory Back Pain
Brett Smith, DO
Sponsored by AbbVie
Vaccination Matters: Understanding and Combating Hesitancy and Disparities in Vaccination
Robert H. Hopkins Jr., MD, FACP, FAAP | Gregory L. Hall, MD
Vaccination is a cornerstone of preventive medicine. However, many individuals fail to receive the benefits of vaccination due to growing vaccine hesitancy and a lack of effective communication about vaccines. This is especially troubling amidst the COVID-19 pandemic, as decisions to decline COVID-19 vaccination present not only increased risk to individuals but also an immediate and massive public health risk. This public health problem is magnified in already health-disparate communities, such as those of Black and Hispanic individuals, in the United States. In this session, Dr. Robert Hopkins and Dr. Gregory Hall will address these concerns by raising PCPs’ awareness of vaccine hesitancy and their understanding of how it affects diverse populations differently. The education will provide PCPs with concrete strategies, including culturally competent communication, to overcome vaccine hesitancy in patients from all backgrounds.
Professor of Internal Medicine and Pediatrics, University of Arkansas for Medical Sciences College of Medicine, Little Rock, AR
Associate Professor of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH, Associate Professor of Internal Medicine, Northeast Ohio Medical University, Rootstown, OH, Assistant Clinical Professor in Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, Director, Center for African American Health, Research, Education & Policy, Cleveland, OH
Supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP
Hitting Diabetes Head-on: Improving Outcomes and Reducing Clinical Inertia with GLP-1 Receptor Agonists
Javier Morales, MD, FACP, FACE | Deborah Hinnen, APN, BC-ADM, CDCES, FAAN
The percentage of individuals with T2D achieving A1C <7% worsened from 2015-2018. Therapeutic inertia—failure to initiate or intensify treatment in a timely manner—is largely responsible for this problem. This program will support PCPs in overcoming therapeutic inertia through timely initiation and advancement of treatment with GLP-1 RAs.
Associate Clinical Professor of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY
Advanced Practice Nurse, Diabetes Clinic, University of Colorado Health, University of Colorado College of Nursing, Wichita State University Graduate Nursing Department, Colorado Springs, CO
Supported by Novo Nordisk, Inc.
When Topicals Aren't Enough: An Oral Non-Biologic Treatment Option for Plaque Psoriasis
Robert Greenberg, MD
Dr. Greenberg will be presenting a current oral, non-biologic treatment option for plaque psoriasis.
The Director of the East Bay Psoriasis Treatment Center
Sponsored by Amgen Inc.
Karol E. Watson, MD, PhD
Heart disease is the leading cause of death for women, and the pathophysiology, prevention strategies, screening, and treatments are often different from men. This session will discuss differences and similarities in heart disease between women and men and offer recommendations for prevention, evaluation and treatment.
Professor of Medicine/Cardiology, David Geffen School of Medicine at UCLA, Co-director, UCLA Program in Preventive Cardiology, David Geffen School of Medicine at UCLA, Director, UCLA Barbra Streisand Women's Heart Health Program, David Geffen School of Medicine at UCLA, Los Angeles, CA
Jan L. Shifren, MD
Sexual problems in women are highly prevalent, often with an adverse impact of quality of life and relationships. Learn the principal causes of female sexual dysfunction and options for effective management in this 60-minute session with an open Q&A period.
Director, Midlife Women's Health Center, Massachusetts General Hospital, Vincent Trustees Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA
Close to the Heart: The Importance of Recognizing Cardiovascular Risk in Type 2 Diabetes
Stephen A. Brunton, MD, FAAFP, CDCES
The objective of this program is to communicate the importance of addressing cardiovascular risk in patients with type 2 diabetes. The program will cover data on prevalence, morbidity, mortality, and intensive versus conventional glucose lowering on macrovascular complications. In addition, the program will review guidance from leading medical associations that is based upon completed cardiovascular outcome trials of antihyperglycemic medications in patients with type 2 diabetes.
Executive Director, Primary Care Metabolic Group, Winnsboro, SC
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC
Exacerbations of COPD: Consequences and Considerations
Stephanie Christenson, MD, MAS
Uncovering the burden of COPD exacerbations may help in generating an appreciation of the range of associated consequences to the patient. This program will define exacerbation severity in COPD, review the possible impact of both moderate and severe COPD exacerbations, and highlight important considerations for appropriate COPD management.
Assistant Professor, Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, University of California, San Francisco
Sponsored by AstraZeneca
Janet Pregler, MD | Martin A. Quan, MD
What do primary care providers need to know about contraception and menopause? Join expert faculty as they review important questions they get asked about these topics!
Director, Iris Cantor-UCLA Women’s Health Center, Professor of Clinical Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA
Professor of Clinical Family Medicine, Director, Office of Continuing Medical Education, David Geffen School of Medicine at UCLA, Los Angeles, CA
Katherine E. Galluzzi, DO, CMD, FACOFP | M. Susan Burke, MD, FACP
This session aims to refresh your knowledge and stimulate interest in performing a thorough and focused physical exam (PE), particularly in the geriatric population. Whether part of a Medicare evaluation or a routine office visit, the PE provides an opportunity to develop rapport, trust, and potentially to discover clinically significant findings that might otherwise have gone unrecognized. A series of brief scenarios will be used to illustrate important yet basic concepts such as differentiation between normal age-related findings versus indicators of worrisome disease processes and atypical presentation of disease. Now, Let’s Get Physical!
Professor and Chair, Department of Geriatrics, Philadelphia College of Osteopathic Medicine, Philadelphia, PA
Clinical Associate Professor of Medicine, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, Senior Advisor, Lankenau Medical Associates, Lankenau Medical Center, Wynnewood, PA
Primary Care Heart Failure Learning Module
Amplifire uses brain science and an adaptive algorithm that adjusts the experience to tailor content to meet your learning needs. Here’s how it’s different: you will be asked questions before you start learning. Research shows that answering questions prepares your brain to learn, and it helps make new concepts stick. In addition, the questions are used to customize your experience.
Sponsored by Novartis Pharmaceutical Corporation
Early Recognition of Interstitial Lung Disease
Justin Oldham, MD, MS
During this virtual Industry Theater presentation, an expert pulmonologist who specializes in the field of interstitial lung diseases (ILDs) will discuss the complexity of ILD recognition, with a focus on diagnostic criteria and the importance of collaborating with specialists for a timely diagnosis of ILDs
Director, Interstitial Lung Disease Program, The University of California at Davis
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.